Effects of Omega-3 Fatty Acids on Bone and Frailty

Status unconfirmed · Phase 4 · Has a placebo group

Conditions studied: Osteoporosis, Frailty

In brief

The purpose of this study is to examine the effects of essential fatty acid (EFA) supplementation on bone metabolism and frailty in postmenopausal women. The overall hypothesis is that EFA supplementation, via its immunoregulatory and anti-inflammatory activity, will decrease bone turnover, decrease prostaglandins and cytokines associated with bone metabolism and frailty, and change physical outcome measures associated with frailty in postmenopausal women with low bone mass and frailty.

Key facts

Study ID
NCT00634686
Run by
Donaghue Medical Research Foundation
People needed
150
Starts
2007-01-01
Expected to finish
2009-06-01
Last updated by the study team
2009-02-02

Who can join

Age: 65 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.